IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v506y2014i7488d10.1038_nature12881.html
   My bibliography  Save this article

Landscape of genomic alterations in cervical carcinomas

Author

Listed:
  • Akinyemi I. Ojesina

    (Dana-Farber Cancer Institute
    The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Lee Lichtenstein

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Samuel S. Freeman

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Chandra Sekhar Pedamallu

    (Dana-Farber Cancer Institute
    The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Ivan Imaz-Rosshandler

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Trevor J. Pugh

    (Dana-Farber Cancer Institute
    The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Andrew D. Cherniack

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Lauren Ambrogio

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Kristian Cibulskis

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Bjørn Bertelsen

    (Haukeland University Hospital, N5021 Bergen, Norway)

  • Sandra Romero-Cordoba

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Victor Treviño

    (Tecnológico de Monterrey, Monterrey 64849, Mexico)

  • Karla Vazquez-Santillan

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Alberto Salido Guadarrama

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Alexi A. Wright

    (Dana-Farber Cancer Institute
    Brigham and Women’s Hospital)

  • Mara W. Rosenberg

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Fujiko Duke

    (Dana-Farber Cancer Institute)

  • Bethany Kaplan

    (Dana-Farber Cancer Institute
    The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Rui Wang

    (Dana-Farber Cancer Institute
    Fudan University Shanghai Cancer Center)

  • Elizabeth Nickerson

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Heather M. Walline

    (Cancer Biology Program, Program in the Biomedical Sciences, Rackham Graduate School, University of Michigan)

  • Michael S. Lawrence

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Chip Stewart

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Scott L. Carter

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Aaron McKenna

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Iram P. Rodriguez-Sanchez

    (Facultad de Medicina y Hospital Universitario ‘Dr. José Eluterio González’ de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México)

  • Magali Espinosa-Castilla

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Kathrine Woie

    (Haukeland University Hospital, N5021 Bergen, Norway)

  • Line Bjorge

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Elisabeth Wik

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Mari K. Halle

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Erling A. Hoivik

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Camilla Krakstad

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Nayeli Belem Gabiño

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Gabriela Sofia Gómez-Macías

    (Facultad de Medicina y Hospital Universitario ‘Dr. José Eluterio González’ de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México)

  • Lezmes D. Valdez-Chapa

    (Facultad de Medicina y Hospital Universitario ‘Dr. José Eluterio González’ de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México)

  • María Lourdes Garza-Rodríguez

    (Facultad de Medicina y Hospital Universitario ‘Dr. José Eluterio González’ de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México)

  • German Maytorena

    (Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico)

  • Jorge Vazquez

    (Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico)

  • Carlos Rodea

    (Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico)

  • Adrian Cravioto

    (Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico)

  • Maria L. Cortes

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Heidi Greulich

    (Dana-Farber Cancer Institute
    The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
    Brigham and Women’s Hospital)

  • Christopher P. Crum

    (Brigham and Women’s Hospital)

  • Donna S. Neuberg

    (Dana-Farber Cancer Institute)

  • Alfredo Hidalgo-Miranda

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Claudia Rangel Escareno

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico
    Claremont Graduate University)

  • Lars A. Akslen

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Thomas E. Carey

    (University of Michigan Comprehensive Cancer Center)

  • Olav K. Vintermyr

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Stacey B. Gabriel

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University)

  • Hugo A. Barrera-Saldaña

    (Facultad de Medicina y Hospital Universitario ‘Dr. José Eluterio González’ de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México)

  • Jorge Melendez-Zajgla

    (Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico)

  • Gad Getz

    (The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
    Massachusetts General Hospital and Harvard Medical School)

  • Helga B. Salvesen

    (Haukeland University Hospital, N5021 Bergen, Norway
    Centre for Cancer Biomarkers, University of Bergen, N5020 Bergen, Norway)

  • Matthew Meyerson

    (Dana-Farber Cancer Institute
    The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
    Brigham and Women’s Hospital)

Abstract

Whole-exome sequencing and analysis of 115 cervical carcinoma–normal paired samples, in addition to transcriptome and whole-genome sequencing for a subset of these tumours, reveal novel genes mutated at significant levels within this cohort and provide evidence that HPV integration is a common mechanism for target gene overexpression; results also compare mutational landscapes between squamous cell carcinomas and adenocarcinomas.

Suggested Citation

  • Akinyemi I. Ojesina & Lee Lichtenstein & Samuel S. Freeman & Chandra Sekhar Pedamallu & Ivan Imaz-Rosshandler & Trevor J. Pugh & Andrew D. Cherniack & Lauren Ambrogio & Kristian Cibulskis & Bjørn Bert, 2014. "Landscape of genomic alterations in cervical carcinomas," Nature, Nature, vol. 506(7488), pages 371-375, February.
    • Handle: RePEc:nat:nature:v:506:y:2014:i:7488:d:10.1038_nature12881
    DOI: 10.1038/nature12881
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature12881
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature12881?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Liyuan Zhou & Qiongzi Qiu & Qing Zhou & Jianwei Li & Mengqian Yu & Kezhen Li & Lingling Xu & Xiaohui Ke & Haiming Xu & Bingjian Lu & Hui Wang & Weiguo Lu & Pengyuan Liu & Yan Lu, 2022. "Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    2. Maisa Pinheiro & Nicolas Wentzensen & Michael Dean & Meredith Yeager & Zigui Chen & Amulya Shastry & Joseph F. Boland & Sara Bass & Laurie Burdett & Thomas Lorey & Sambit Mishra & Philip E. Castle & M, 2024. "Somatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    3. Ankur Chakravarthy & Ian Reddin & Stephen Henderson & Cindy Dong & Nerissa Kirkwood & Maxmilan Jeyakumar & Daniela Rothschild Rodriguez & Natalia Gonzalez Martinez & Jacqueline McDermott & Xiaoping Su, 2022. "Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    4. Xiaoli Wang & Wenlong Jia & Mengyao Wang & Jihong Liu & Xianrong Zhou & Zhiqing Liang & Qinghua Zhang & Sixiang Long & Suolang Quzhen & Xiangchun Li & Qiang Tian & Xiong Li & Haiying Sun & Caili Zhao , 2022. "Human papillomavirus integration perspective in small cell cervical carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:506:y:2014:i:7488:d:10.1038_nature12881. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.